查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1503369

至 2030 年慢性傷口護理市場預測 - 按產品（高級傷口敷料、治療設備、主動傷口護理和其他產品）、傷口類型、最終用戶和地理位置進行的全球分析

Chronic Wound Care Market Forecasts to 2030 - Global Analysis By Product (Advanced Wound Dressings, Therapy Devices, Active Wound Care and Other Products), Wound Type, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2024 年全球慢性傷口護理市場規模為 154.3 億美元，預計到 2030 年將達到 220.2 億美元，預測期內複合年成長率為 8.6%。慢性傷口護理涉及對未能在預期時間範圍內（通常超過三個月）正常癒合階段進行的傷口的治療和管理。有效的慢性傷口照護包括徹底評估、清創、控制感染、水分平衡和解決潛在問題。它通常需要多學科方法，整合先進療法、病患教育和持續監測，以促進癒合並預防併發症。

根據醫療保健研究與品質機構的數據，美國每年有超過 250 萬人患有壓瘡。

市場動態：

司機：

糖尿病和肥胖症發生率上升

由於癒合過程受損和免疫力下降，糖尿病患者和肥胖者更容易出現慢性傷口，例如潰瘍和感染。因此，對先進傷口護理產品和療法以有效管理這些病症的需求不斷增加。需求的激增推動了慢性傷口護理市場的創新和擴張，促進了專業治療和技術的發展，以滿足不斷成長的患者需求。

克制：

發展中地區的認知有限

發展中地區對慢性傷口護理的認知有限，往往是由於醫療保健專業人員缺乏教育和培訓、公共衛生舉措不足以及獲得先進醫療技術的機會有限。這種認知的缺乏導致診斷和治療不足，延長患者的痛苦並增加醫療費用。因此，由於對先進傷口護理產品和服務的需求仍然較低，市場成長受到阻礙，阻礙了這些地區的投資和創新。

機會：

政府支持舉措

政府的支持性措施為研究和開發提供資金，確保更好的醫療基礎設施，並提高患者獲得先進治療的機會。這些改善了臨床結果，同時監管部門的批准加快了創新傷口護理產品的上市。此外，報銷計劃減輕了患者的經濟負擔，並鼓勵使用先進的傷口護理療法。這些共同努力為慢性傷口護理解決方案的市場擴張和創新創造了有利的環境。

威脅：

治療費用高

由於癒合時間長、需要專門的治療、頻繁的就診和先進的傷口護理產品，慢性傷口護理的治療成本很高。這些成本對於醫療保健系統和患者來說可能是巨大的，導致財務緊張。此外，慢性傷口的複雜性需要持續創新，這進一步增加了成本並為市場擴張造成了障礙。

Covid-19 影響

covid-19 大流行擾亂了供應鏈、推遲了擇期手術以及將醫療資源轉移到緊急應變上，從而對慢性傷口護理市場產生了重大影響。許多患者獲得常規護理的機會減少，導致傷口狀況惡化。然而，它也加速了遠距醫療和遠端監控技術的採用，加強了慢性傷口的管理。總體而言，這場大流行凸顯了針對慢性病建立有彈性和適應性的醫療保健系統的必要性。

治療設備領域預計將在預測期內成為最大的領域

治療設備領域預計將出現利潤豐厚的成長。治療設備有助於傷口癒合和管理，在慢性傷口護理中發揮著至關重要的作用。這些設備包括負壓傷口治療系統、高壓氧艙、電刺激設備和超音波設備。它們具有多種治療功效，例如促進血液循環、減少細菌負荷、增強組織再生和維持濕潤的傷口環境。有效使用治療設備對於改善慢性傷口患者的治療效果和加速其癒合過程至關重要。

預計糖尿病足潰瘍部分在預測期內複合年成長率最高

預計糖尿病足潰瘍部分在預測期內複合年成長率最高。糖尿病足潰瘍的慢性傷口護理著重於管理和治癒這些複雜傷口的專門治療。它涉及多學科方法，包括清創、卸載、感染控制和根據糖尿病患者需求量身定做的先進敷料。治療介入措施旨在預防感染和截肢等併發症，促進更快的康復並提高生活品質。定期監測和病患教育對於有效管理糖尿病足潰瘍和預防復發至關重要。

佔比最大的地區：

由於人口老化、糖尿病和肥胖症盛行率上升以及醫療保健意識不斷提高，預計亞太地區在預測期內將佔據最大的市場佔有率。中國、印度和日本等國家憑藉其龐大的患者群體和不斷擴大的醫療基礎設施正在推動市場成長。在政府措施和不斷增加的醫療支出的支持下，先進傷口護理產品和技術的採用也在增加。

複合年成長率最高的地區：

由於其先進的醫療基礎設施，預計北美在預測期內的複合年成長率最高。美國和加拿大在創新傷口護理產品和技術的研發方面投入大量資金，引領市場。強力的報銷政策、廣泛的意識以及主要市場參與者的存在進一步支持了成長。此外，該地區人口老化以及糖尿病和肥胖症的高盛行率推動了市場的成長。

主要進展：

2023 年 5 月，3M 已達成協議，將總部位於德國塞費爾德的牙科局部麻醉產品組合相關的某些資產出售給全球製藥業服務提供商 Pierrel SpA（「Pierrel」），以換取收購價格為7000 萬美元，有待成交和其他調整。

2023年1月，Mimedx與Gunze Medical Limited簽訂了獨家經銷協議，在日本銷售用於傷口癒合的胎盤組織同種異體移植物Epifix。根據該協議，該公司旨在加強其在日本市場的地位。

我們的報告提供了什麼：

  • 區域和國家層面的市場佔有率評估
  • 對新進入者的策略建議
  • 涵蓋2022年、2023年、2024年、2026年及2030年的市場資料
  • 市場趨勢（促進因素、限制因素、機會、威脅、挑戰、投資機會和建議）
  • 根據市場預測提出關鍵業務部門的策略建議
  • 競爭性景觀美化繪製主要共同趨勢
  • 公司概況，包括詳細的策略、財務狀況和最新發展
  • 反映最新技術進步的供應鏈趨勢

免費客製化產品：

本報告的所有客戶都將有權獲得以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 個）
    • 關鍵參與者的 SWOT 分析（最多 3 個）
  • 區域細分
    • 根據客戶的興趣對任何主要國家的市場估計、預測和複合年成長率（註：取決於可行性檢查）
  • 競爭基準化分析
    • 根據產品組合、地理分佈和策略聯盟對主要參與者基準化分析

目錄

第 1 章：執行摘要

第 2 章：前言

  • 抽象的
  • 股東
  • 研究範圍
  • 研究方法論
    • 資料探勘
    • 數據分析
    • 數據驗證
    • 研究方法
  • 研究來源
    • 主要研究來源
    • 二手研究來源
    • 假設

第 3 章：市場趨勢分析

  • 介紹
  • 促進要素
  • 限制
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • Covid-19 的影響

第 4 章：波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭競爭

第 5 章：全球慢性傷口護理市場：依產品分類

  • 介紹
  • 進階傷口敷料
    • 水膠體敷料
    • 海藻酸鹽敷料
    • 泡棉敷料
    • 水凝膠敷料
    • 膠原蛋白敷料
  • 治療設備
    • 負壓傷口治療 (NPWT)
    • 高壓氧治療 (HBOT)
    • 電刺激裝置
    • 超音波治療設備
  • 積極的傷口護理
    • 生長因子
    • 皮膚替代品
    • 幹細胞治療
    • 生物工程皮膚
  • 其他產品

第 6 章：全球慢性傷口護理市場：依傷口類型

  • 介紹
  • 糖尿病足潰瘍
  • 壓瘡
  • 腿部靜脈潰瘍
  • 動脈潰瘍
  • 手術傷口
  • 其他傷口類型

第 7 章：全球慢性傷口護理市場：按最終用戶

  • 介紹
  • 醫院
  • 專科診所
  • 家庭醫療保健
  • 其他最終用戶

第 8 章：全球慢性傷口護理市場：按地理位置

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 亞太地區其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 中東和非洲其他地區

第 9 章：主要進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 擴充
  • 其他關鍵策略

第 10 章：公司概況

  • The 3M Healthcare Company
  • Johnson & Johnson
  • Smith & Nephew PLC
  • Mimedx Group
  • Integra LifeSciences
  • Molnlycke Health Care
  • ConvaTec Group plc
  • Coloplast A/S
  • Medline Industries Inc.
  • MPM Medical Inc.
  • Organogenesis Inc.
  • Hollister Incorporated
  • B. Braun Melsungen AG
  • Hartmann Group
  • Medtronic PLC
Product Code: SMRC26536

According to Stratistics MRC, the Global Chronic Wound Care Market is accounted for $15.43 billion in 2024 and is expected to reach $22.02 billion by 2030 growing at a CAGR of 8.6% during the forecast period. Chronic wound care involves the treatment and management of wounds that fail to progress through the normal stages of healing within an expected timeframe, typically over three months. Effective chronic wound care includes thorough assessment, debridement, infection control, moisture balance, and addressing underlying conditions. It often requires a multidisciplinary approach, integrating advanced therapies, patient education, and continuous monitoring to promote healing and prevent complications.

According to Agency for Healthcare Research and Quality, more than 2.5 million people in the U.S. develop pressure ulcers every year.

Market Dynamics:

Driver:

Rising incidence of diabetes and obesity

Diabetic patients and obese individuals are more prone to chronic wounds such as ulcers and infections due to impaired healing processes and reduced immunity. Consequently, there is a heightened demand for advanced wound care products and therapies to manage these conditions effectively. This surge in demand drives innovation and expansion within the chronic wound care market, fostering the development of specialized treatments and technologies to address the increasing patient needs.

Restraint:

Limited awareness in developing regions

Limited awareness of chronic wound care in developing regions is often due to a lack of education and training among healthcare professionals, insufficient public health initiatives, and limited access to advanced medical technologies. This lack of awareness results in inadequate diagnosis and treatment, prolonging patient suffering and increasing healthcare costs. Consequently, the market growth is hampered as the demand for advanced wound care products and services remains low, hindering investments and innovations in these regions.

Opportunity:

Supportive government initiatives

Supportive government initiatives provide funding for research and development, ensuring better healthcare infrastructure, and enhancing patient access to advanced treatments. These improve clinical outcomes, while regulatory approvals expedite the availability of innovative wound care products. Additionally, reimbursement schemes reduce the financial burden on patients, encouraging the use of advanced wound care therapies. These combined efforts foster a conducive environment for market expansion and innovation in chronic wound care solutions.

Threat:

High treatment costs

Chronic wound care has high treatment costs due to prolonged healing times, the need for specialized treatments, frequent medical visits, and advanced wound care products. These costs can be substantial for healthcare systems and patients, leading to financial strain. Additionally, the complexity of chronic wounds demands continuous innovations, further escalating costs and creating barriers for market expansion.

Covid-19 Impact

The covid-19 pandemic significantly impacted the chronic wound care market by disrupting supply chains, delaying elective procedures, and shifting healthcare resources to emergency responses. Many patients experienced reduced access to routine care, exacerbating wound conditions. However, it also accelerated the adoption of telemedicine and remote monitoring technologies, enhancing chronic wound management. Overall, the pandemic highlighted the need for resilient and adaptable healthcare systems for chronic conditions.

The therapy devices segment is expected to be the largest during the forecast period

The therapy devices segment is estimated to have a lucrative growth. Therapy devices play a crucial role in chronic wound care by aiding in wound healing and management. These devices include negative pressure wound therapy systems, hyperbaric oxygen chambers, electrical stimulation devices, and ultrasound devices. They provide various therapeutic benefits such as promoting blood circulation, reducing bacterial load, enhancing tissue regeneration, and maintaining a moist wound environment. Effective use of therapy devices is essential in improving outcomes and accelerating the healing process for patients with chronic wounds.

The diabetic foot ulcers segment is expected to have the highest CAGR during the forecast period

The diabetic foot ulcers segment is anticipated to witness the highest CAGR growth during the forecast period. Chronic wound care for diabetic foot ulcers focuses on specialized treatments to manage and heal these complex wounds. It involves a multidisciplinary approach including debridement, offloading, infection control, and advanced dressings tailored to diabetic patient's needs. Therapeutic interventions aim to prevent complications like infections and amputations, promoting faster healing and improved quality of life. Regular monitoring and patient education are crucial in managing diabetic foot ulcers effectively and preventing recurrence.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period due to aging population, increasing prevalence of diabetes and obesity, and rising healthcare awareness. Countries like China, India, and Japan are driving market growth with their large patient populations and expanding healthcare infrastructure. The adoption of advanced wound care products and technologies is also on the rise, supported by government initiatives and increasing healthcare expenditure.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, owing to its advanced healthcare infrastructure. The U.S. and Canada lead the market with significant investments in research and development of innovative wound care products and technologies. Strong reimbursement policies, widespread awareness, and the presence of key market players further support growth. Further, aging population along with high prevalence of diabetes and obesity in the region fuels the market growth.

Key players in the market

Some of the key players profiled in the Chronic Wound Care Market include The chronic wound care market includes a range of companies such as 3M Healthcare Company, Johnson & Johnson, Smith & Nephew PLC, Mimedx Group, Integra LifeSciences, Molnlycke Health Care, ConvaTec Group plc, Coloplast A/S, Medline Industries Inc., MPM Medical Inc., Organogenesis Inc., Hollister Incorporated, B. Braun Melsungen AG, Hartmann Group, and Medtronic PLC.

Key Developments:

In May 2023, 3M has entered into agreements to sell certain assets associated with its dental local anesthetic portfolio, based in Seefeld, Germany, to Pierrel S.p.A. (""Pierrel""), a global provider of services for the pharmaceutical industry, for a purchase price of $70 million, subject to closing and other adjustments.

In January 2023, Mimedx entered into an exclusive distribution agreement with Gunze Medical Limited to sell placental tissue allograft, Epifix for wound healing in Japan. Upon this agreement, the company aims at strengthening its position in the Japan market.

Products Covered:

  • Advanced Wound Dressings
  • Therapy Devices
  • Active Wound Care
  • Other Products

Wound Types Covered:

  • Diabetic Foot Ulcers
  • Pressure Ulcers
  • Venous Leg Ulcers
  • Arterial Ulcers
  • Surgical Wounds
  • Other Wound Types

End Users Covered:

  • Hospitals
  • Specialty Clinics
  • Home Healthcare
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Chronic Wound Care Market, By Product

  • 5.1 Introduction
  • 5.2 Advanced Wound Dressings
    • 5.2.1 Hydrocolloid Dressings
    • 5.2.2 Alginate Dressings
    • 5.2.3 Foam Dressings
    • 5.2.4 Hydrogel Dressings
    • 5.2.5 Collagen Dressings
  • 5.3 Therapy Devices
    • 5.3.1 Negative Pressure Wound Therapy (NPWT)
    • 5.3.2 Hyperbaric Oxygen Therapy (HBOT)
    • 5.3.3 Electrical Stimulation Devices
    • 5.3.4 Ultrasound Therapy Devices
  • 5.4 Active Wound Care
    • 5.4.1 Growth Factors
    • 5.4.2 Skin Substitutes
    • 5.4.3 Stem Cell Therapy
    • 5.4.4 Bioengineered Skin
  • 5.5 Other Products

6 Global Chronic Wound Care Market, By Wound Type

  • 6.1 Introduction
  • 6.2 Diabetic Foot Ulcers
  • 6.3 Pressure Ulcers
  • 6.4 Venous Leg Ulcers
  • 6.5 Arterial Ulcers
  • 6.6 Surgical Wounds
  • 6.7 Other Wound Types

7 Global Chronic Wound Care Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Specialty Clinics
  • 7.4 Home Healthcare
  • 7.5 Other End Users

8 Global Chronic Wound Care Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 The 3M Healthcare Company
  • 10.2 Johnson & Johnson
  • 10.3 Smith & Nephew PLC
  • 10.4 Mimedx Group
  • 10.5 Integra LifeSciences
  • 10.6 Molnlycke Health Care
  • 10.7 ConvaTec Group plc
  • 10.8 Coloplast A/S
  • 10.9 Medline Industries Inc.
  • 10.10 MPM Medical Inc.
  • 10.11 Organogenesis Inc.
  • 10.12 Hollister Incorporated
  • 10.13 B. Braun Melsungen AG
  • 10.14 Hartmann Group
  • 10.15 Medtronic PLC

List of Tables

  • Table 1 Global Chronic Wound Care Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Chronic Wound Care Market Outlook, By Product (2022-2030) ($MN)
  • Table 3 Global Chronic Wound Care Market Outlook, By Advanced Wound Dressings (2022-2030) ($MN)
  • Table 4 Global Chronic Wound Care Market Outlook, By Hydrocolloid Dressings (2022-2030) ($MN)
  • Table 5 Global Chronic Wound Care Market Outlook, By Alginate Dressings (2022-2030) ($MN)
  • Table 6 Global Chronic Wound Care Market Outlook, By Foam Dressings (2022-2030) ($MN)
  • Table 7 Global Chronic Wound Care Market Outlook, By Hydrogel Dressings (2022-2030) ($MN)
  • Table 8 Global Chronic Wound Care Market Outlook, By Collagen Dressings (2022-2030) ($MN)
  • Table 9 Global Chronic Wound Care Market Outlook, By Therapy Devices (2022-2030) ($MN)
  • Table 10 Global Chronic Wound Care Market Outlook, By Negative Pressure Wound Therapy (NPWT) (2022-2030) ($MN)
  • Table 11 Global Chronic Wound Care Market Outlook, By Hyperbaric Oxygen Therapy (HBOT) (2022-2030) ($MN)
  • Table 12 Global Chronic Wound Care Market Outlook, By Electrical Stimulation Devices (2022-2030) ($MN)
  • Table 13 Global Chronic Wound Care Market Outlook, By Ultrasound Therapy Devices (2022-2030) ($MN)
  • Table 14 Global Chronic Wound Care Market Outlook, By Active Wound Care (2022-2030) ($MN)
  • Table 15 Global Chronic Wound Care Market Outlook, By Growth Factors (2022-2030) ($MN)
  • Table 16 Global Chronic Wound Care Market Outlook, By Skin Substitutes (2022-2030) ($MN)
  • Table 17 Global Chronic Wound Care Market Outlook, By Stem Cell Therapy (2022-2030) ($MN)
  • Table 18 Global Chronic Wound Care Market Outlook, By Bioengineered Skin (2022-2030) ($MN)
  • Table 19 Global Chronic Wound Care Market Outlook, By Other Products (2022-2030) ($MN)
  • Table 20 Global Chronic Wound Care Market Outlook, By Wound Type (2022-2030) ($MN)
  • Table 21 Global Chronic Wound Care Market Outlook, By Diabetic Foot Ulcers (2022-2030) ($MN)
  • Table 22 Global Chronic Wound Care Market Outlook, By Pressure Ulcers (2022-2030) ($MN)
  • Table 23 Global Chronic Wound Care Market Outlook, By Venous Leg Ulcers (2022-2030) ($MN)
  • Table 24 Global Chronic Wound Care Market Outlook, By Arterial Ulcers (2022-2030) ($MN)
  • Table 25 Global Chronic Wound Care Market Outlook, By Surgical Wounds (2022-2030) ($MN)
  • Table 26 Global Chronic Wound Care Market Outlook, By Other Wound Types (2022-2030) ($MN)
  • Table 27 Global Chronic Wound Care Market Outlook, By End User (2022-2030) ($MN)
  • Table 28 Global Chronic Wound Care Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 29 Global Chronic Wound Care Market Outlook, By Specialty Clinics (2022-2030) ($MN)
  • Table 30 Global Chronic Wound Care Market Outlook, By Home Healthcare (2022-2030) ($MN)
  • Table 31 Global Chronic Wound Care Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.